Catalogo dei prodotti della ricerca

FILETTI, SEBASTIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.466
EU - Europa 2.980
AS - Asia 1.918
SA - Sud America 78
AF - Africa 50
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.367
IT - Italia 1.184
SG - Singapore 627
IN - India 612
CN - Cina 580
UA - Ucraina 561
SE - Svezia 354
FI - Finlandia 310
DE - Germania 115
GB - Regno Unito 90
IE - Irlanda 88
CA - Canada 78
AR - Argentina 58
RU - Federazione Russa 49
BE - Belgio 48
ID - Indonesia 46
NL - Olanda 45
FR - Francia 40
BG - Bulgaria 39
TG - Togo 31
MX - Messico 19
RO - Romania 18
CH - Svizzera 13
EC - Ecuador 12
IR - Iran 11
JP - Giappone 9
ZA - Sudafrica 9
KR - Corea 7
TR - Turchia 7
BR - Brasile 5
ES - Italia 4
PL - Polonia 4
SC - Seychelles 4
AF - Afghanistan, Repubblica islamica di 3
AT - Austria 3
CL - Cile 3
HK - Hong Kong 3
LT - Lituania 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
AU - Australia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
PT - Portogallo 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
BD - Bangladesh 1
BZ - Belize 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EU - Europa 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
TH - Thailandia 1
VN - Vietnam 1
Totale 19.498
Salva come PNG Salva come JPEG
Città #
Fairfield 2.542
Woodbridge 1.401
Houston 1.082
Ann Arbor 1.035
Ashburn 998
Seattle 872
Cambridge 810
Wilmington 730
Chandler 673
Singapore 447
Dearborn 439
Rome 402
San Paolo di Civitate 391
Princeton 358
Plano 282
Lawrence 250
Beijing 234
Boston 208
Jacksonville 202
San Diego 168
Santa Clara 154
Des Moines 130
Millbury 117
Dublin 88
Andover 83
Norwalk 77
Federal 56
Toronto 56
Fremont 54
Boardman 49
New York 48
Hefei 45
Helsinki 45
Jakarta 43
Sofia 39
Nanjing 37
Brussels 31
Falls Church 31
Lomé 31
Kunming 28
Jinan 26
Phoenix 25
Moscow 22
Mannheim 21
London 20
Nanchang 18
Bühl 16
Falkenstein 16
Guangzhou 16
Waanrode 16
Milan 15
Ottawa 14
Indiana 13
Fort Worth 12
San Mateo 12
Bologna 11
Leawood 11
Paris 11
San Jose 11
Shanghai 11
Shenyang 11
Munich 10
Los Angeles 9
Mexico City 9
Velletri 9
Bremen 8
Buffalo 8
Guayaquil 8
Hangzhou 8
Philadelphia 8
Pune 8
Sacramento 8
Zhengzhou 8
Bari 7
Carraia Nord 7
Redwood City 7
Verona 7
Auburn Hills 6
Hebei 6
Istanbul 6
Latina 6
Padova 6
Basel 5
Cagliari 5
Catania 5
Fuzhou 5
Monterotondo 5
Montréal 5
Silverton 5
Southend 5
Springfield 5
Tappahannock 5
Taranto 5
Trumbull 5
Turin 5
Xian 5
Ambato 4
Changsha 4
Chaoyang 4
Chiba 4
Totale 15.339
Salva come PNG Salva come JPEG
Nome #
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study 188
Follicular thyroid cancer and Hurthle cell carcinoma: Challenges in diagnosis, treatment, and clinical management 135
Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer 128
Real-world performance of the American Thyroid Association Risk estimates in predicting 1-year differentiated thyroid cancer outcomes: a prospective multicenter study of 2000 patients 126
DIABETE DI TIPO 2. Dalla diagnosi al controllo metabolico ottimale 123
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. 123
A case of severe occult ectopic adrenocorticotropin syndrome treated with retrograde venous adrenal ablation using ethanol 119
Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules 116
8th edition of AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2) 115
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: a case report 114
Identification of thyroid-associated serum microRNA profiles and their potential use in thyroid cancer follow-up 111
Follow-up of differentiated thyroid cancer – what should (and what should not) be done 105
Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: towards the "right" TIRADS 104
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 100
Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetes 100
Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas 100
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment. 99
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study 98
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 97
HABP2 Mutation and Nonmedullary Thyroid Cancer 97
Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound 96
Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments 96
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 96
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization 96
Follow-up of low risk patients with papillary thyroid cancer: Role of neck ultrasonography in detecting lymph node metastases 95
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR (R): Biodistribution, pharmacokinetic features and in vivo antitumor activity 94
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 94
MicroRNA-based molecular classification of papillary thyroid carcinoma 94
Liraglutide and cardiovascular outcomes in type 2 diabetes 94
Mapping a dominant form of multinodular goiter to chromosome Xp22. 93
The natural history of benign thyroid nodules 93
Sonographically estimated risks of malignancy for thyroid nodules computed with five standard classification systems. Changes over time and their relation to malignancy 93
Stimulation of iodide uptake by human chorionic gonadotropin in FRTL-5 cells: effects on sodium/iodide symporter gene and protein expression 92
Expression of pendrin and the Pendred Syndrome (PDS) gene in human thyroid tissues 92
A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism 91
Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family 91
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 91
A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens 90
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial 88
Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk 88
Expression of Na+/I- symporter and pendred syndrome genes in trophoblast cells 87
Temporal Changes in Thyroid Nodule Volume: Lack of Effect on Paranodular Thyroid Tissue Volume 87
THE ROLE OF THYROID-STIMULATING ANTIBODIES OF GRAVES-DISEASE IN DIFFERENTIATED THYROID-CANCER 87
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors 86
Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement? 86
A radioimmunoassay for human thyroglobulin: methodology and clinical applications. 86
Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients 86
An unusual association of cerebral meningioma, parathyroid adenoma and thyroid papillary carcinoma 85
Screening for differentiated thyroid cancer in selected populations 85
TSH receptor extracellular region mutations in thyroid functioning nodules: further evidence for the functional role of this region in the receptor activation 85
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas 84
Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells 84
Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells 84
ACTIVATING MUTATIONS OF THE TSH RECEPTOR IN DIFFERENTIATED THYROID CARCINOMAS 83
Familial medullary thyroid carcinoma: Clinical variability and low aggressiveness associated with RET mutation at codon 804 83
Taller-than-wide shape: a new definition improves the specificity of TIRADS systems 83
Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes 82
BRAF V600E -mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response 82
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency 81
When intensive insulin therapy (MDi) fails in patients with type 2 diabetes: Switching to GLP-1 receptor agonist versus insulin pump 81
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas 81
Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells 81
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules 80
Na+/I- symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues 80
Iodide symporter gene expression in human thyroid tumors 79
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAFV600E mutation 79
Expression of the Sodium/Iodide Symporter in Human Prostate Adenocarcinoma 79
Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells 79
Clinical implications of BRAF mutation in thyroid carcinoma 79
Transaminase levels in the upper normal range are associated with oral hypoglycemic drug therapy failure in patients with type 2 diabetes 79
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 78
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells 78
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 78
Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: A SNP array-based linkage analysis of 38 families 77
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals 77
Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies 77
A genetic based disease management in inherited cancer syndromes: the multiple endrocrine neoplasia model 77
Multiple catecholamine-secreting paragangliomas: Diagnosis after hemorrhagic stroke in a young woman 77
Thyroid-specific transcription factors control Hex promoter activity 77
Na(+)/I(-) symporter distribution in human thyroid tissues: An immunohistochemical study 76
Mutational analysis of Peroxiredoxin IV: exclusion of a positional candidate for multinodular goitre. 76
Expression of PAX8 target genes in papillary thyroid carcinoma 76
Recent advances in managing differentiated thyroid cancer 76
Epigenetics of thyroid cancer and novel therapeutic targets 75
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates 75
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer 75
Expression of the Na(+)/I(-) symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes 74
Radioiodinated recombinant human TSH: A novel radiopharmaceutical for thyroid cancer metastases detection 74
Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies 74
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors 74
Identification of a Neck Lump as a Lymph Node Metastasis from an Occult Contralateral Papillary Microcarcinoma of the Thyroid: Key Role of Thyroglobulin Assay in the Fine-Needle Aspirate 74
RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma 73
Mortality in elderly patients with subclinical hyperthyroidism 73
Multiple endocrine neoplasia 2 73
Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report 73
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 73
Mapping a dominant form of multinodular goiter to chromosome Xp22 73
Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas 73
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours 73
Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines 72
Totale 8.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.684 0 0 0 0 0 868 869 654 594 373 172 154
2020/20212.096 178 260 95 136 46 175 108 225 251 324 203 95
2021/20223.335 18 236 377 60 387 94 103 378 225 249 536 672
2022/20232.947 657 824 102 239 248 327 24 160 230 25 61 50
2023/20241.162 74 196 46 89 91 115 60 60 2 165 121 143
2024/2025954 119 59 237 176 172 191 0 0 0 0 0 0
Totale 19.968